Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and …

ES Stroes, PD Thompson, A Corsini… - European heart …, 2015 - academic.oup.com
Statin-associated muscle symptoms (SAMS) are one of the principal reasons for statin non-
adherence and/or discontinuation, contributing to adverse cardiovascular outcomes. This …

Cholesterol-Lowering Effects of Probiotics and Prebiotics: A Review of in Vivo and in Vitro Findings

LG Ooi, MT Liong - International journal of molecular sciences, 2010 - mdpi.com
Probiotics are live microorganisms that promote health benefits upon consumption, while
prebiotics are nondigestible food ingredients that selectively stimulate the growth of …

The perspective on cholesterol‐lowering mechanisms of probiotics

N Ishimwe, EB Daliri, BH Lee, F Fang… - Molecular nutrition & …, 2015 - Wiley Online Library
The use of probiotics as food components combats not only cardiovascular diseases but
also many gastrointestinal tract disorders. Their health benefits along with their increased …

[HTML][HTML] Small rodent models of atherosclerosis

Y Zhao, H Qu, Y Wang, W Xiao, Y Zhang… - Biomedicine & …, 2020 - Elsevier
The ease of breeding, low cost of maintenance, and relatively short period for developing
atherosclerosis make rodents ideal for atherosclerosis research. However, none of the …

Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic …

B Dong, M Wu, H Li, FB Kraemer, K Adeli… - Journal of lipid …, 2010 - ASBMB
We investigated the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in the
resistance of dyslipidemic hamsters to statin-induced LDL-cholesterol (LDL-C) reduction …

Guinea pig models for translation of the developmental origins of health and disease hypothesis into the clinic

JL Morrison, KJ Botting, JRT Darby… - The Journal of …, 2018 - Wiley Online Library
Abstract Over 30 years ago Professor David Barker first proposed the theory that events in
early life could explain an individual's risk of non‐communicable disease in later life: the …

Human skeletal muscle drug transporters determine local exposure and toxicity of statins

MJ Knauer, BL Urquhart… - Circulation …, 2010 - Am Heart Assoc
Rationale: The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, or statins, are
important drugs used in the treatment and prevention of cardiovascular disease. Although …

[HTML][HTML] Treatment options for statin-associated muscle symptoms

U Laufs, H Scharnagl, M Halle, E Windler… - Deutsches Ärzteblatt …, 2015 - ncbi.nlm.nih.gov
Background About 4.6 million persons in Germany are now taking statins, ie, drugs that
inhibit the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. Statins …

A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment

BK Podell, DF Ackart, MA Richardson… - Disease models & …, 2017 - journals.biologists.com
Type 2 diabetes is a leading cause of morbidity and mortality among noncommunicable
diseases, and additional animal models that more closely replicate the pathogenesis of …

Dietary α-tocopherol and atorvastatin reduce high-fat-induced lipid accumulation and down-regulate CD36 protein in the liver of guinea pigs

MC Podszun, N Grebenstein, A Spruss… - The Journal of nutritional …, 2014 - Elsevier
The increased uptake and storage of lipids in the liver are important features of steatotic liver
diseases. The fatty acid translocase/scavenger receptor cluster of differentiation (CD) 36 …